Evidence map›Paper›PMID 32968690›Full record

ArticleOpen forum infectious diseases2020

Impact of a 24/7 Rapid Molecular Assay for Influenza Detection on the Prescription of Oseltamivir.

Hervé Jacquier, Gauthier Péan de Ponfilly, Anthony Chauvin, Rishma Amarsy, Hana Benmansour, Dan-Thanh Hoang-Nguyen, Emmanuel Lecorché, Céline Mesnil, Faiza Mougari, Anne-Lise Munier and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open forum infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Hervé JacquierLaboratory of Microbiology, Infectious Agents Department, Saint Louis-Lariboisiere-Fernand Widal Hospital Group, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.ORCID 0000-0002-6323-5910
Gauthier Péan de PonfillyLaboratory of Microbiology, Infectious Agents Department, Saint Louis-Lariboisiere-Fernand Widal Hospital Group, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
Anthony ChauvinEmergency Department, Saint Louis-Lariboisiere-Fernand Widal Hospital Group, APHP, Paris, France.
Rishma AmarsyInfection Control Department, Saint Louis-Lariboisiere-Fernand Widal Hospital Group, APHP, Paris, France.
Hana BenmansourLaboratory of Microbiology, Infectious Agents Department, Saint Louis-Lariboisiere-Fernand Widal Hospital Group, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
Dan-Thanh Hoang-NguyenPharmacy, Saint Louis-Lariboisiere-Fernand Widal Hospital Group, APHP, Paris, France.
Emmanuel LecorchéLaboratory of Microbiology, Infectious Agents Department, Saint Louis-Lariboisiere-Fernand Widal Hospital Group, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
Céline MesnilEmergency Department, Saint Louis-Lariboisiere-Fernand Widal Hospital Group, APHP, Paris, France.
Faiza MougariLaboratory of Microbiology, Infectious Agents Department, Saint Louis-Lariboisiere-Fernand Widal Hospital Group, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
Anne-Lise MunierDepartment of Infectious Diseases, Saint Louis-Lariboisiere-Fernand Widal University Hospital, APHP, Paris, France.
Maud SalmonaUnit of Virology and Graft, Infectious Agents Department, Saint Louis-Lariboisiere-Fernand Widal University Hospital, APHP, Paris, France.
Béatrice BerçotLaboratory of Microbiology, Infectious Agents Department, Saint Louis-Lariboisiere-Fernand Widal Hospital Group, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
Jérôme Le GoffUnit of Virology and Graft, Infectious Agents Department, Saint Louis-Lariboisiere-Fernand Widal University Hospital, APHP, Paris, France.
Emmanuelle CambauLaboratory of Microbiology, Infectious Agents Department, Saint Louis-Lariboisiere-Fernand Widal Hospital Group, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We assessed the impact of a rapid molecular assay for influenza detection whether outsourced or performed onsite 24/7 in a University Hospital in Paris, France. Shorter median time-to-results (16.8 vs 2.3 hours,

Indexed as

adequacy of oseltamivir prescriptionflumicrobial diagnosistime-to-resultXpert Flu/RSV XC assay

Identifiers

PMID32968690
PMCPMC7494179

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.